Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06049849 · ClinicalTrials.gov registry record · NA

Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators

A NA study of Chronic Stroke, sponsored by First Institute of All Medicines.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT06049849 is a NA study of Chronic Stroke that has completed, run by First Institute of All Medicines. The registered enrollment target is 46 participants, above the 41-participant average among 20 other Chronic Stroke trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06049849, a NA study of Chronic Stroke, has completed, sponsored by First Institute of All Medicines.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

Study objective The purpose of this clinical research is to verify if the patient with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. Study design This study is a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. At least 46 patients with chronic stroke will participate in the live-in observational study in a Tesla MedBed Center. Study patient population The adult patient with a chronic stroke which was defined as a stroke occurred at least 6 months ago with a significant disability unable to have an independent life, is to be considered as a qualified participant.

Conditions Studied

Interventions

  • DEVICE Biophoton Energizing Brain and Whole Body

Study Locations (1)

Pennsylvania

  • Tesla MedBed Center at Butler-PA - Butler

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2023-10-31
Est. Completion 2024-12-31
Phase NA

Sponsor

First Institute of All Medicines

6 total trials

What the Registry Record Tells You About NCT06049849

The ClinicalTrials.gov registry entry for NCT06049849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 41-participant average among 20 other Chronic Stroke trials with a reported enrollment target (12% higher). The listed sponsor is First Institute of All Medicines, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Biophoton Energizing Brain and Whole Body is the first listed.

NCT06049849 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06049849 about?

NCT06049849 is a clinical study titled "Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators". Study objective The purpose of this clinical research is to verify if the patient with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. Study design This study is a...

What is the current status of trial NCT06049849?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2023-10-31. Estimated completion is 2024-12-31.

What conditions does trial NCT06049849 study?

This clinical trial studies the following conditions: Chronic Stroke.

What interventions are being tested in trial NCT06049849?

The interventions under investigation include: Biophoton Energizing Brain and Whole Body (DEVICE).

Who is sponsoring clinical trial NCT06049849?

This trial is sponsored by First Institute of All Medicines, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06049849 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.